Oak Ridge Investments’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $967K | Sell |
70,570
-3,134
| -4% | -$42.9K | 0.07% | 115 |
|
|
2025
Q1 | $815K | Buy |
73,704
+12,539
| +21% | +$139K | 0.07% | 122 |
|
|
2024
Q4 | $651K | Sell |
61,165
-15,634
| -20% | -$167K | 0.05% | 137 |
|
|
2024
Q3 | $975K | Sell |
76,799
-3,130
| -4% | -$39.8K | 0.09% | 111 |
|
|
2024
Q2 | $1.34M | Buy |
79,929
+18,725
| +31% | +$314K | 0.13% | 101 |
|
|
2024
Q1 | $918K | Buy |
+61,204
| New | +$918K | 0.09% | 121 |
|